Analyst Price Targets — BODI
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 11, 2026 12:37 pm | George Kelly | Roth Capital | $9.00 | $8.88 | TheFly | Beachbody Company price target lowered to $9 from $13 at Roth Capital |
| May 13, 2026 12:15 pm | — | Roth Capital | $13.00 | $13.55 | TheFly | Beachbody Company price target raised to $13 from $10 at Roth Capital |
| May 5, 2026 10:48 am | — | Canaccord Genuity | $19.00 | $13.68 | TheFly | Beachbody Company price target raised to $19 from $15 at Canaccord |
| May 17, 2024 5:42 am | Susan Anderson | Canaccord Genuity | $13.00 | $8.64 | StreetInsider | Canaccord Genuity Starts Beachbody Company (BODI) at Buy, 'getting lean to get stronger' |
| May 7, 2024 7:59 am | George Kelly | Roth Capital | $14.00 | $9.44 | TheFly | Beachbody Company price target lowered to $14 from $15 at Roth MKM |
Latest News for BODI
Beachbody NASDAQ: BODI Executive Chairman Mark Goldston outlined the company's turnaround progress, retail expansion plans and product pipeline at a Canaccord consumer conference, saying the company has shifted away from its former multilevel marketing structure toward a direct-to-consumer and retail-focused wellness strategy.
The Beachbody Company, Inc. (BODI) Q2 2026 Earnings Call Transcript
The Beachbody Company, Inc. (BODI) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.14 per share. This compares to a loss of $0.57 per share a year ago.
Beachbody NASDAQ: BODI reported second-quarter 2026 revenue of $49.6 million, exceeding the midpoint of its guidance range, while extending its streak of positive operating income, net income and adjusted EBITDA as the company continues shifting toward a nutrition-led, multi-channel model.
EL SEGUNDO, Calif.--(BUSINESS WIRE)--The Beachbody Company, Inc. (NASDAQ: BODi) (“BODi” or the “Company”), the proactive wellness company delivering nutrition, supplements, and proven fitness programs that help people take control of their health inside and out, today announced financial results for its second quarter ended June 30, 2026. “Q2 marks our fourth consecutive quarter of net income and operating income,…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for BODI.
U.S. House Trading
No House trades found for BODI.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.